Sign in
Taking peopleNo phase

Following adults with primary hyperparathyroidism over time after parathyroid surgery

Follows adults with primary hyperparathyroidism to see how surgery affects their health.

Key facts

Who runs it
Nantes University Hospital
Where
France1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Cohort Primary Hyperparathyroidism
Status
Recruiting
People taking part
403 people, planned
Started
31 Mar 2016
Expected to end
24 Feb 2027
Type of study
Observational
Record updated
8 September 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults diagnosed with primary hyperparathyroidism at Nantes University Hospital. It follows how they do after surgery to remove the parathyroid glands (parathyroidectomy).

Age
Over 18 years
Sex
All sexes
Disease stage
Primary hyperparathyroidism (overactive parathyroid glands not caused by another condition)

Main reasons for not taking part

  • Under 18 years old
  • Pregnant or breastfeeding
  • Adults under legal guardianship
  • Secondary or tertiary hyperparathyroidism
  • Multiple endocrine neoplasia (an inherited condition causing tumours in hormone glands)

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Age > 18

Who cannot take part

  • Age < 18
  • Pregnancy / lactation
  • Adults underguardianship
  • Secondary/tertiary hyperparathyroidism
  • Multiple endocrine neoplasia

This trial is currently available in France.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

CoHPT is a prospective, monocentric, observational cohort including all patients diagnosed with primary hyperparathyroidism in Nantes University Hospital, aiming to study the outcomes associated with parathyroidectomy. Clinical and biochemical evaluation is performed at the inclusion, and 6, 12, 36 and 60 months. A biocollection is collected. The main hypotheses are that parathyroidectomy could improve cardiovascular, renal, bone, and cardiovascular outcomes along with quality of life.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Prospective Cohort Primary Hyperparathyroidism
Plain-language title
Following adults with primary hyperparathyroidism over time after parathyroid surgeryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Publications
Record updated
8 September 2025